Flagship Pioneering’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-38,506,526
| Closed | -$6.55M | – | 12 |
|
|
2022
Q4 | $6.55M | Hold |
38,506,526
| – | – | 0.21% | 9 |
|
|
2022
Q3 | $16.6M | Hold |
38,506,526
| – | – | 0.7% | 9 |
|
|
2022
Q2 | $32.7M | Hold |
38,506,526
| – | – | 1.23% | 9 |
|
|
2022
Q1 | $212M | Hold |
38,506,526
| – | – | 4.98% | 3 |
|
|
2021
Q4 | $373M | Hold |
38,506,526
| – | – | 5.76% | 3 |
|
|
2021
Q3 | $688M | Hold |
38,506,526
| – | – | 7.21% | 3 |
|
|
2021
Q2 | $940M | Hold |
38,506,526
| – | – | 12.01% | 2 |
|
|
2021
Q1 | $1.02B | Buy |
38,506,526
+210,000
| +0.5% | +$5.57M | 16.34% | 3 |
|
|
2020
Q4 | $291M | Hold |
38,296,526
| – | – | 5.29% | 4 |
|
|
2020
Q3 | $192M | Hold |
38,296,526
| – | – | 5.3% | 5 |
|
|
2020
Q2 | $229M | Hold |
38,296,526
| – | – | 6.65% | 2 |
|
|
2020
Q1 | $170M | Hold |
38,296,526
| – | – | 7.99% | 2 |
|
|
2019
Q4 | $364M | Hold |
38,296,526
| – | – | 20.34% | 2 |
|
|
2019
Q3 | $301M | Hold |
38,296,526
| – | – | 16.45% | 2 |
|
|
2019
Q2 | $602M | Hold |
38,296,526
| – | – | 26.07% | 2 |
|
|
2019
Q1 | $693M | Hold |
38,296,526
| – | – | 26.23% | 2 |
|
|
2018
Q4 | $616M | Hold |
38,296,526
| – | – | 30.07% | 2 |
|
|
2018
Q3 | $919M | Buy |
+38,296,526
| New | +$919M | 60.75% | 1 |
|